Wealth Advisory Solutions’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15.1M Sell
16,388
-5,576
-25% -$5.65M 3.36% 6
2025
Q4
$23.6M Sell
21,964
-172
-0.8% -$164K 5.5% 4
2025
Q3
$16.9M Buy
22,136
+2,920
+15% +$2.17M 4.09% 4
2025
Q2
$15M Buy
19,216
+45
+0.2% +$35K 3.79% 4
2025
Q1
$15.8M Buy
19,171
+2,924
+18% +$2.43M 4.19% 5
2024
Q4
$12.5M Buy
16,247
+355
+2% +$294K 3.51% 6
2024
Q3
$14.1M Sell
15,892
-494
-3% -$444K 3.88% 6
2024
Q2
$14.8M Sell
16,386
-1,600
-9% -$1.28M 4.02% 6
2024
Q1
$14M Sell
17,986
-35
-0.2% -$24.9K 3.62% 6
2023
Q4
$10.5M Buy
18,021
+300
+2% +$175K 3.67% 5
2023
Q3
$9.52M Sell
17,721
-3,423
-16% -$1.76M 1.86% 12
2023
Q2
$9.92M Sell
21,144
-1,018
-5% -$427K 2.64% 7
2023
Q1
$7.61M Sell
22,162
-4,386
-17% -$1.48M 2.02% 13
2022
Q4
$9.71M Sell
26,548
-1,987
-7% -$705K 2.61% 10
2022
Q3
$9.23M Sell
28,535
-988
-3% -$313K 2.55% 7
2022
Q2
$9.57M Buy
29,523
+1,584
+6% +$475K 2.36% 8
2022
Q1
$8M Buy
+27,939
New +$7.19M 1.66% 16
2021
Q3
$6.94M Sell
30,050
-239
-0.8% -$59K 1.54% 13
2021
Q2
$6.95M Buy
30,289
+504
+2% +$101K 1.65% 12
2021
Q1
$6K Sell
29,785
-32,899
-52% -$6.44M ﹤0.01% 73
2020
Q4
$10.5M Buy
62,684
+264
+0.4% +$39.4K 2.85% 4
2020
Q3
$9.24M Buy
62,420
+23,695
+61% +$3.67M 2.45% 5
2020
Q2
$6.36M Sell
38,725
-247
-0.6% -$37.9K 1.77% 10
2020
Q1
$5.41M Sell
38,972
-7,653
-16% -$1.05M 1.84% 10
2019
Q4
$6.13M Buy
+46,625
New +$5.4M 1.61% 12

Other funds holding LLY

Wealth Advisory Solutions's LLY Position: Q1 2026 in Review

Wealth Advisory Solutions reduced its Eli Lilly (LLY) stake by 25% in Q1 2026, selling an estimated $5.65M and leaving 16,388 shares worth $15.1M. The position accounts for 3.36% of the portfolio, ranked #6.

Wealth Advisory Solutions first reported a position in LLY in Q4 2019 and has held it in 25 quarters since. The position peaked at $23.6M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Wealth Advisory Solutions held 16,388 shares of Eli Lilly worth $15.1M as of Q1 2026.
  • Wealth Advisory Solutions sold 5,576 Eli Lilly shares in Q1 2026, an estimated $5.65M.
  • Eli Lilly made up 3.36% of Wealth Advisory Solutions's portfolio in Q1 2026, its #6 holding.
  • Wealth Advisory Solutions first reported a position in Eli Lilly in Q4 2019 and has held it in 25 quarters since.
  • Wealth Advisory Solutions's Eli Lilly position peaked at $23.6M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Wealth Advisory Solutions's 13F filing for Q1 2026, filed 22 Apr 2026.